Pioneering adipose tissue research to unlock the next generation of regenerative aesthetics.

Linio Biotech is not building a single injectable product — we are building a regenerative platform based on a deep, proprietary understanding of human adipose tissue and its role in skin and soft-tissue regeneration.

Unlike conventional aesthetic companies that focus on temporary volume replacement, Linio’s technology is designed to activate the body’s own regenerative mechanisms, enabling natural, durable outcomes in a scalable, ready-to-use format.

This positions Linio Biotech at the intersection of:

• Regenerative medicine
• Medical aesthetics
• Biologically active injectables

— a convergence that defines the next growth phase of the industry.

For years, our team has studied human adipose tissue: how it regenerates, how it supports skin health, and how it can be used to restore soft tissue naturally and safely. This research forms the foundation of Tience®, our platform technology for skin defect treatment, already used by clinicians in the Nordics.

Because of our world-leading knowledge in adipose-derived science, we are able to develop next-generation regenerative products leveraging Tience technology, that harness the body’s own natural mechanisms. Our work brings together advanced cell biology and modern biomaterials to create solutions that are both effective and easy for clinicians to use.